Over the past twenty years, the challenge of sustainability for caprolactam (CPL) has gone from a dream to reality. Different players have different strategies to achieve that. In recent years there have been several serious initiatives in this area announced by market leaders. Wood Mackenzie is currently working with some caprolactam partners to set up a GHG (CO2 footprint) indicator initially for European units and secondly for all caprolactam units before launching into other products in the polyamide chain. Our schedule foresees an experimental publication in our monthly report during Q3 of this year. Read the insight for more information on this topic.